Actively Recruiting
Randomized Placebo-Controlled Crossover Study of Oral Cannabidiol Epidiolex to Assess Neurobehavioral and Functional Effects in Children with Sanfilippo Syndrome
Led by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center · Updated on 2026-09-15
35
Participants Needed
1
Research Sites
87 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying cannabidiol CBD as a potential treatment for Sanfilippo syndrome, a rare genetic disorder causing progressive neurodegeneration and severe neurobehavioral symptoms. The study aims to evaluate the safety of cannabidiol and explore its effects on behavior and functional outcomes in children with this condition. Currently, no approved treatments exist for the neurobehavioral problems caused by Sanfilippo syndrome, making this research important for patients and families. Participants will be divided into two groups based on enrollment order. The first five participants will receive Epidiolex, a pharmaceutical-grade oral cannabidiol solution, to assess safety. The next 30 participants will be randomly assigned to receive either Epidiolex or a placebo for 16 weeks, followed by an 8-week period without treatment. Then, they will switch to the opposite treatment for another 16 weeks. After this blinded crossover phase, all participants will receive Epidiolex openly for 52 weeks to assess long-term safety. Throughout the study, caregivers will complete surveys about the participants behavior, mood, sleep, pain, and caregiver stress. Clinical evaluations and safety labs will be conducted regularly to monitor safety and treatment effects. The main measurement focuses on changes in mood, anger, and aggression over the treatment and placebo periods. Participants are expected to be involved for the entire study duration, including the crossover and long-term treatment phases.
CONDITIONS
Brief Title
Study of Cannabidiol in Sanfilippo Syndrome
Research Team
A
Adolfo Morales Garval, BA
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here